Literature DB >> 22568431

Utility weights for the vision-related Assessment of Quality of Life (AQoL)-7D instrument.

Jeff Richardson1, Angelo Iezzi, Stuart Peacock, Kompal Sinha, Munir Khan, RoseAnne Misajon, Jill Keeffe.   

Abstract

PURPOSE: To obtain utility weights consistent with the needs of economic evaluation for the Assessment of Quality of Life (AQoL)-7D, a generic instrument created to increase the sensitivity of the measurement of quality of life amongst people with impaired vision.
METHODS: Two extant instruments were combined, the Vision-related Quality of Life Index (VisQoL) and the AQoL-6D. Utilities were obtained from patients with visual impairment and from the general population using time trade-off (TTO) methodology. Dimensions were combined and an econometric adjustment used to eliminate the effects of instrument redundancy. Bias was tested by comparison of holistic TTO values with utility scores predicted from the AQoL-7D scoring formula.
RESULTS: The AQoL-7D instrument consists of 26 items and 7 dimensions each with good psychometric properties. Their combination into a single instrument resulted in significant redundancy which was successfully eliminated. Utility formulae for both the public and patients produced bias-free estimates of the utility of holistic health states describing visual impairment. Results imply differing valuations of health states by the public and by people with impaired vision.
CONCLUSIONS: The AQoL-7D can detect changes in health states affecting people with impaired vision which are likely to be overlooked by other generic instruments due to content insensitivity. The utilities it produces are generated using a "mainstream" methodology, the TTO. Quality-adjusted life year values based on the AQoL-7D may therefore be used for economic evaluation of programs.

Entities:  

Mesh:

Year:  2012        PMID: 22568431     DOI: 10.3109/09286586.2012.674613

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  9 in total

1.  Deriving population norms for the AQoL-6D and AQoL-8D multi-attribute utility instruments from web-based data.

Authors:  Aimee Maxwell; Mehmet Özmen; Angelo Iezzi; Jeff Richardson
Journal:  Qual Life Res       Date:  2016-06-25       Impact factor: 4.147

2.  Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China.

Authors:  Yanhui Si; Shunping Li; Yanjiao Xu; Gang Chen
Journal:  Qual Life Res       Date:  2021-12-02       Impact factor: 4.147

Review 3.  Dimensions Used in Instruments for QALY Calculation: A Systematic Review.

Authors:  Moustapha Touré; Christian R C Kouakou; Thomas G Poder
Journal:  Int J Environ Res Public Health       Date:  2021-04-21       Impact factor: 3.390

4.  Construction of the descriptive system for the Assessment of Quality of Life AQoL-6D utility instrument.

Authors:  Jeffrey R J Richardson; Stuart J Peacock; Graeme Hawthorne; Angelo Iezzi; Gerald Elsworth; Neil A Day
Journal:  Health Qual Life Outcomes       Date:  2012-04-17       Impact factor: 3.186

5.  Preference-based disease-specific health-related quality of life instrument for glaucoma: a mixed methods study protocol.

Authors:  Sergei Muratov; Dominik W Podbielski; Susan M Jack; Iqbal Ike K Ahmed; Levine A H Mitchell; Monika Baltaziak; Feng Xie
Journal:  BMJ Open       Date:  2016-11-08       Impact factor: 2.692

6.  SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration.

Authors:  Martijn S Visser; Sankha Amarakoon; Tom Missotten; Reinier Timman; Jan J Busschbach
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

7.  Development of a balanced instrument to measure global health-related quality of life: The 13-MD.

Authors:  Moustapha Touré; Alain Lesage; Thomas G Poder
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

8.  Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial.

Authors:  Ecosse L Lamoureux; Rachel Mcintosh; Marios Constantinou; Eva K Fenwick; Jing Xie; Robert Casson; Eric Finkelstein; Ivan Goldberg; Paul Healey; Ravi Thomas; Ghee Soon Ang; Konrad Pesudovs; Jonathan Crowston
Journal:  Trials       Date:  2015-09-11       Impact factor: 2.279

9.  The Utility of Economic Measures to Quantify the Burden of Tinnitus in Affected Individuals: A Scoping Review.

Authors:  Elza Daoud; Charlotte Caimino; Michael A Akeroyd; Arnaud J Noreña; David M Baguley
Journal:  Pharmacoecon Open       Date:  2021-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.